We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Results 1 to 5 of 10
Most popular |Most recent


Advocate General: the use of unfertilised human ova is patentable

European Union, Netherlands - September 10 2014 In International Stem Cell Corporation, the Advocate General of the European Court of Justice recently opined that parthenogenetically activated...

Jan Pieter Hustinx, Ilja Morée, Gertjan Kuipers.


ECJ opens door to SPCs for safeners in plant protection products

European Union, Netherlands - July 9 2014 The European Court of Justice (ECJ) has decided that a safener can fall within the definition of an 'active substance' as outlined in Articles 1.8...

Jan Pieter Hustinx, Ilja Morée, Gertjan Kuipers, Tjibbe Douma.


New Technology Transfer Block Exemption now in effect: stricter regime

European Union - June 11 2014 The revised Technology Transfer Block Exemption Regulation (TTBER) and accompanying guidelines entered into force on 1 May 2014. Certain changes...

Jan Pieter Hustinx, Bart de Rijke, Gertjan Kuipers, Roos van der Poel, Erik Pijnacker Hordijk.


Supreme Court: clearly worded patent claim’s scope can be limited

Netherlands - May 12 2014 On 4 April 2014, the Dutch Supreme Court ruled on Medinol v Abbottconcerning the scope of protection of patents. The Supreme Court held that the...

Jan Pieter Hustinx, Gertjan Kuipers.


AG’s opinion brings additional plant protection for safeners closer

European Union - March 10 2014 The ECJ ruled in GSK Biologics that an adjuvant that is part of a medical product, which adjuvant influences the therapeutic effects of the active...

Jan Pieter Hustinx, Ilja Morée, Gertjan Kuipers, Tjibbe Douma.